UBS Group AG - CASCADIAN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 78 filers reported holding CASCADIAN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,000
-85.7%
295
-83.3%
0.00%–
Q3 2017$7,000
+133.3%
1,770
+107.7%
0.00%–
Q2 2017$3,000
-94.3%
852
-93.4%
0.00%–
Q1 2017$53,000
+5200.0%
12,822
+5112.2%
0.00%–
Q4 2016$1,000–246–0.00%–
 Download
Other shareholders

There were no reported owners of CASCADIAN THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of CASCADIAN THERAPEUTICS INC shareholders